Effect of an olive-oil bioactive extract on basal TEER (A) and TNF-α induced decrease in TEER (B) <i>in vitro</i>. by Martin Liehr (3863431)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

Effects of ROCK inhibitors H-1152 and Y-27632 on TNF-induced MLC phosphorylation, actin and CL5 reorganization and the fall in TEER. by Paul R. Clark (714064)

Requirement of NF-κB activation for cytokine-mediated reductions in TEER. by Paul R. Clark (714064)

Immunohistochemical staining and analysis of NF-κB activation in cytokine- and α-MSH-treated Caco-2 cells. by Judit Váradi (507449)

Secretion of IL-6 and IL-8 in Caco-2 cells treated with cytokines and α-MSH. by Judit Váradi (507449)

Dose- and time-dependent effect of IFN-γ and TNF-α on benzamil-sensitive <i>I</i>_sc and TEER in HBECs. by Anusree Sasidharan (19226521)

Dose- and time-dependent effect of IL-13, IL-4, and TGF-β1 on benzamil-sensitive <i>I</i>_sc and TEER in HBECs. by Anusree Sasidharan (19226521)

P2X7 modulates migration and the epithelial-mesenchymal phenotype. by José David Nuñez-Ríos (18823719)

Effects of 1,25(OH)₂D₃ on transendothelial electrical resistance (TEER) in bEnd.3 cells under hypoxia/reoxygenation (H/R). by Soonmi Won (713581)

“…<p><b>(A)</b> TEER was decreased by H/R. The decrease was significantly prevented by pretreatment with 1,25(OH)₂D₃ (Vit D) at 20, 50, 100, and 200 nM. …”

Kinetics and dose response of distinct changes to HDMEC barriers induced by TNF and IL-β. by Paul R. Clark (714064)

“…B: TNF induction of an early TEER rise and a bi-phasic TEER decrease. Labels indicate the peak of the early TEER increase and two distinct phases of TEER decrease (as nadirs to phases 1 and 2). …”

Video 5_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

Data Sheet 2_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

Data Sheet 3_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

Video 3_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

Video 6_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

Video 1_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

Data Sheet 1_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

Video 7_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

Video 2_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)